{"abstract":"This is notice, in accordance with 35 U.S.C. 209 and 37 CFR Part 404, that the National Institutes of Health, Department of Health and Human Services, is contemplating the grant of an exclusive patent license to practice the inventions embodied in the following U.S. Patents and Patent Applications to Scion Cardio-vascular (\"Scion\") located in Miami, FL, USA.","action":"Notice.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"National Institutes of Health","name":"National Institutes of Health","id":353,"url":"https://www.federalregister.gov/agencies/national-institutes-of-health","json_url":"https://www.federalregister.gov/api/v1/agencies/353","parent_id":221,"slug":"national-institutes-of-health"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2013/11/25/2013-28119.html","cfr_references":[],"citation":"78 FR 70308","comment_url":null,"comments_close_on":"2013-12-26","correction_of":null,"corrections":[],"dates":"Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before December 26, 2013 will be considered.","disposition_notes":null,"docket_ids":[],"dockets":[],"document_number":"2013-28119","effective_on":null,"end_page":70309,"executive_order_notes":null,"executive_order_number":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2013/11/25/2013-28119.xml","html_url":"https://www.federalregister.gov/documents/2013/11/25/2013-28119/prospective-grant-of-exclusive-license-development-of-chitosanil-12-conjugate-as-immunotherapeutic","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/2013-28119?publication_date=2013-11-25","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2013-11-25/2013-28119/mods.xml","not_received_for_publication":null,"page_length":2,"page_views":{"count":101,"last_updated":"2026-09-22 04:15:07 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2013-11-25/pdf/2013-28119.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2013-28119.pdf?1385128565","publication_date":"2013-11-25","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2013/11/25/2013-28119.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[],"comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=NIH_FRDOC_0001","supporting_documents_count":0,"docket_id":"NIH_FRDOC_0001","regulation_id_number":null,"title":"Recently Posted NIH Rules and Notices.","checked_regulationsdotgov_at":"2013-12-28T05:00:50Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":70308,"subtype":null,"title":"Prospective Grant of Exclusive License: Development of Chitosan/IL-12 Conjugate as Immunotherapeutic Products for Human Cancers","toc_doc":"Development of Chitosan/IL12 Conjugate as Immunotherapeutic Products for Human Cancers","toc_subject":"Exclusive Licenses:","topics":[],"type":"Notice","volume":78}